Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.4935
+0.0305 (6.59%)
Sep 22, 2026, 4:00 PM EDT - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $7.6 million as of September 22, 2026. Its market cap has decreased by -27.35% in one year.
Market Cap
7.60M
Enterprise Value
9.43M
1-Year Change
-27.35%
Ranking
Category
Stock Price
$0.49
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.60M, a decrease of -72.86%. That is a compound annual growth rate of -6.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 8.03M | -2.31% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 8.62M |
| Soligenix | 8.05M |
| Exicure | 8.05M |
| Longeveron | 7.94M |
| XTL Biopharmaceuticals | 7.87M |
| Skye Bioscience | 7.81M |
| Imunon | 7.63M |
| Traws Pharma | 7.53M |